Physician profile
Blake Edward Peterson
NPI 1023379849
$381,752.61
in general payments reported to CMS, 2019-2025
24 companies · $184K in 2025
The $184K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,353 · 2020: $39K · 2021: $26K · 2022: $39K · 2023: $52K · 2024: $34K · 2025: $184K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $177K · Consulting Fee: $66K · Travel and Lodging: $22K · Food and Beverage: $4,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $176,937.50 |
| Consulting Fee | $66,010.00 |
| Travel and Lodging | $22,232.62 |
| Food and Beverage | $4,266.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $367,789.14 | 2019-2025 | Avenir, G7, Arcos |
| Smith+Nephew, INC. | $10,291.17 | 2020-2025 | Journey II, Real Intelligence, K-15 Pork |
| Stryker Corporation | $1,330.23 | 2019-2025 | Mako, Insignia, Triathlon |
| Globus Medical, INC. | $817.33 | 2025 | Creo, Adira, Excelsius Gps |
| Kci USA, INC. | $800.00 | 2020 | |
| Medical Device Business Services, INC. | $114.14 | 2019 | |
| Davol INC. | $79.95 | 2021-2023 | Arista Ah Flexitip |
| Ferring Pharmaceuticals INC. | $78.21 | 2022-2024 | Euflexxa |
| Mimedx Group, INC. | $73.62 | 2024 | |
| Radius Health, INC. | $56.11 | 2019-2023 | Tymlos |
| Amgen INC. | $53.99 | 2019-2023 | Prolia, Evenity |
| Depuy Synthes Sales INC. | $39.31 | 2020 | |
| Convatec INC. | $34.53 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $30.47 | 2025 | |
| Solventum Corporation | $25.12 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $19.14 | 2024 | Novosorb Btm |
| Acumed LLC | $18.41 | 2023 | Inframe Implant, Innate Implant, Acumed |
| Heraeus Medical, LLC. | $17.44 | 2019 | |
| Bard Access Systems, INC. | $17.21 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $15.66 | 2019 | |
| Baudax Bio INC. | $13.36 | 2020 | |
| Pacira Therapeutics, INC. | $13.08 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.07 | 2024 | Exparel, Zilretta, Iovera |
| Pfizer INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.